{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:23:13Z","timestamp":1784661793113,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Carbonic anhydrases (CAs) catalyze the synthesis of HCO\n                    <jats:sub>3<\/jats:sub>\n                    <jats:sup>-<\/jats:sup>\n                    from H\n                    <jats:sub>2<\/jats:sub>\n                    O and CO\n                    <jats:sub>2.<\/jats:sub>\n                    The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secretion. We previously reported that carbonic anhydrase I (CA1), a CA family member, was highly expressed in atherosclerotic tissues of the aorta and stimulated atherosclerosis (AS) by promoting calcification. MTZ showed therapeutic and preventive effects on AS in a mouse model. The above findings suggest a relationship between AS and glaucoma. This study explored the possible association between AS prevalence and glaucoma prevalence and the therapeutic effect of MTZ on AS by analyzing medical records. Among 10,751 patients with a primary diagnosis of glaucoma, 699 (6.5%) were also diagnosed with AS. However, the incidences of AS in patients with keratitis and scleritis, which are also ophthalmic diseases, were 2.5% (206\/8383 patients) and 3.5% (46\/1308 patients), respectively. In the population without ophthalmic records, the AS prevalence was only 1.9% (99,416\/5,168,481 patients) (all\n                    <jats:italic>p<\/jats:italic>\n                    values between each group were below 0.001). Among 152,425 patients with a primary diagnosis of AS, 1245 (0.82%) were also diagnosed with glaucoma. Among 199,782 patients with a primary diagnosis of hypertension (excluding AS), 1149 (0.57%) were diagnosed with glaucoma, and among 5,313,433 patients without AS or hypertension, 9513 (0.18%) were diagnosed with glaucoma (all\n                    <jats:italic>p<\/jats:italic>\n                    values between each group were below 0.001). Additionally, among 14 patients who suffered from both AS and glaucoma and were treated with MTZ to cure their glaucoma, 9 of them showed reduced low-density lipoprotein (LDL) levels, the main index of AS, within 3\u00a0months after medication use (2.81\u2009\u00b1\u20090.61\u00a0mmol\/L vs. 2.38\u2009\u00b1\u20090.58\u00a0mmol\/L,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.039). The above findings demonstrated a strong relation between AS and glaucoma and suggested that AS patients with glaucoma were more likely to suffer from angle-closure glaucoma.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-88322-4","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T06:10:11Z","timestamp":1619071811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Strong association of glaucoma with atherosclerosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Xianqin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"88322_CR1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and treatment of glaucoma a review. J. Am. Med. Assoc. 311, 1901\u20131911 (2014).","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"88322_CR2","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1111\/aos.13983","volume":"97","author":"S Biswas","year":"2019","unstructured":"Biswas, S. & Wan, K. H. Review of rodent hypertensive glaucoma models. Acta Ophthalmol. 97(3), e331\u2013e340 (2019).","journal-title":"Acta Ophthalmol."},{"issue":"9","key":"88322_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4155\/fmc.11.69","volume":"3","author":"CT Supuran","year":"2011","unstructured":"Supuran, C. T. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med. Chem. 3(9), 1165\u20131180 (2011).","journal-title":"Future Med. Chem."},{"key":"88322_CR4","doi-asserted-by":"crossref","unstructured":"Lindskog, S., ScienceDirectcom\u2014pharmacology and therapeutics\u2014structure and mechanism of carbonic anhydrase. 1997. 74(1): 1\u201320.","DOI":"10.1016\/S0163-7258(96)00198-2"},{"issue":"2","key":"88322_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov. 7(2), 168\u2013181 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"88322_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jmg.40.4.257","volume":"40","author":"S-Y Liao","year":"2003","unstructured":"Liao, S.-Y. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. J. Med. Genet. 40(4), 257\u2013261 (2003).","journal-title":"J. Med. Genet."},{"issue":"10","key":"88322_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/13543776.2019.1679117","volume":"29","author":"CT Supuran","year":"2019","unstructured":"Supuran, C. T., Altamimi, A. S. A. & Carta, F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013\u20132019. Expert Opin. Ther. Patents 29(10), 781\u2013792 (2019).","journal-title":"Expert Opin. Ther. Patents"},{"issue":"Pt 2","key":"88322_CR8","first-page":"156","volume":"105","author":"T Krupin","year":"1986","unstructured":"Krupin, T., Wax, M. & Moolchandani, J. Aqueous production. Trans. Ophthalmol. Soc. 105(Pt 2), 156 (1986).","journal-title":"Trans. Ophthalmol. Soc."},{"key":"88322_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejphar.2017.09.007","volume":"816","author":"JL Johnson","year":"2017","unstructured":"Johnson, J. L. Metalloproteinases in atherosclerosis. Eur. J. Pharmacol. 816, 93\u2013106 (2017).","journal-title":"Eur. J. Pharmacol."},{"issue":"7347","key":"88322_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby, P., Ridker, P. M. & Hansson, G. R. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347), 317 (2011).","journal-title":"Nature"},{"key":"88322_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fphar.2019.00766","volume":"10","author":"Y Lin","year":"2019","unstructured":"Lin, Y. et al. Carbonic anhydrase 1-mediated calcification is associated with atherosclerosis, and methazolamide alleviates its pathogenesis. Front. Pharmacol. 10, 766 (2019).","journal-title":"Front. Pharmacol."},{"key":"88322_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/bjophthalmol-2014-305925","volume":"99","author":"Y Sungmin","year":"2015","unstructured":"Sungmin, Y. et al. Intraocular pressure and coronary artery calcification in asymptomatic men and women. Br. J. Ophthalmol. 99, 932\u2013936 (2015).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"88322_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.17305\/bjbms.2009.2863","volume":"9","author":"S Pavljasevi\u0107","year":"2009","unstructured":"Pavljasevi\u0107, S. & As\u0107eri\u0107, M. Primary open-angle glaucoma and serum lipids. Bos. J. Basic Med. Sci. 9(1), 85\u201388 (2009).","journal-title":"Bos. J. Basic Med. Sci."},{"issue":"8","key":"88322_CR14","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.3390\/ijms21082992","volume":"21","author":"NV Mushenkova","year":"2020","unstructured":"Mushenkova, N. V. et al. Current advances in the diagnostic imaging of atherosclerosis: insights into the pathophysiology of vulnerable plaque. Int. J. Mol. Sci. 21(8), 2992 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"88322_CR15","first-page":"1","volume":"2015","author":"A Melissa","year":"2015","unstructured":"Melissa, A. et al. Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors. BioMed Res. Int. 2015, 1\u201315 (2015).","journal-title":"BioMed Res. Int."},{"issue":"1","key":"88322_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbamcr.2010.09.018","volume":"1813","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells. Biochim. Biophys. Acta 1813(1), 159\u2013167 (2010).","journal-title":"Biochim. Biophys. Acta"},{"issue":"18","key":"88322_CR17","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.ejca.2010.07.020","volume":"46","author":"J Tostain","year":"2010","unstructured":"Tostain, J. et al. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur. J. Cancer 46(18), 3141\u20133148 (2010).","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"88322_CR18","first-page":"931","volume":"9","author":"Q Yang","year":"2016","unstructured":"Yang, Q. et al. Overexpression of carbonic anhydrase 1 in pterygium. Int. J. Ophthalmol. 9(6), 931 (2016).","journal-title":"Int. J. Ophthalmol."},{"key":"88322_CR19","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1111\/j.1582-4934.2008.00580.x","volume":"13","author":"P Sansone","year":"2009","unstructured":"Sansone, P. et al. Cyclooxygenase-2\/carbonic anhydrase-IX upregulation promotes invasive potential and hypoxia survival in colorectal cancer cells. J. Cell. Mol. Med. 13, 3876\u20133887 (2009).","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"88322_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1748-717X-5-101","volume":"5","author":"CW Yoo","year":"2010","unstructured":"Yoo, C. W. et al. Carbonic anhydrase XII expression is associated with histologic grade of cervical cancer and superior radiotherapy outcome. Radiat. Oncol. 5(1), 101\u2013101 (2010).","journal-title":"Radiat. Oncol."},{"key":"88322_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-11-1","volume":"11","author":"X Chang","year":"2010","unstructured":"Chang, X. et al. Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskelet. Disord. 11, 1\u201311 (2010).","journal-title":"BMC Musculoskelet. Disord."},{"issue":"4","key":"88322_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3929","volume":"14","author":"X Chang","year":"2012","unstructured":"Chang, X. et al. Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis. Arthritis Res. Ther. 14(4), 1\u201314 (2012).","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"88322_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/1471-2474-13-256","volume":"13","author":"Y Zheng","year":"2012","unstructured":"Zheng, Y. et al. Transgenic mice overexpressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction. BMC Musculoskelet. Disord. 13(1), 256\u2013256 (2012).","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"88322_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-15-1","volume":"15","author":"Y Zheng","year":"2015","unstructured":"Zheng, Y. et al. CA1 contributes to microcalcification and tumorigenesis in breast cancer. BMC Cancer 15(1), 1\u201315 (2015).","journal-title":"BMC Cancer"},{"key":"88322_CR25","doi-asserted-by":"publisher","first-page":"101066","DOI":"10.1016\/j.redox.2018.101066","volume":"23","author":"CB Afonso","year":"2018","unstructured":"Afonso, C. B. & Spickett, C. M. Lipoproteins as targets and markers of lipoxidation. Redox Biol. 23, 101066 (2018).","journal-title":"Redox Biol."},{"issue":"1","key":"88322_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein, J. L. & Brown, M. S. A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161(1), 161\u2013172 (2015).","journal-title":"Cell"},{"issue":"10","key":"88322_CR27","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet, M., Barrett, T. J. & Fisher, E. A. HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease. Circ. Res. 124(10), 1505\u20131518 (2019).","journal-title":"Circ. Res."},{"key":"88322_CR28","first-page":"142","volume":"51","author":"J Stephen","year":"2019","unstructured":"Stephen, J. et al. HDL and cardiovascular disease. Pathology 51, 142\u2013147 (2019).","journal-title":"Pathology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88322-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88322-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88322-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:20:46Z","timestamp":1670034046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88322-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88322"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88322-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-129234\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8792"}}